Analyst Price Targets — BHST
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 19, 2026 9:53 am | Sean McGowan | Roth Capital | $10.00 | $4.45 | TheFly | BioHarvest Sciences initiated with a Buy at Roth Capital |
| May 5, 2025 12:26 pm | Matthew Hewitt | Craig-Hallum | $15.00 | $6.37 | TheFly | Craig-Hallum bullish on BioHarvest Sciences, initiates with a Buy |
| December 18, 2024 12:52 pm | Anthony Vendetti | Maxim Group | $12.00 | $6.20 | TheFly | BioHarvest Sciences initiated with a Buy at Maxim |
Latest News for BHST
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said on Wednesday it has received a 4.33 million NIS (about $1.4 million) grant from the Israel Innovation Authority to fund a new research initiative applying machine learning and computer vision to its plant cell culture programs. The non-dilutive funding, BioHarvest's second grant from the IIA this year, will support integration of data science, chemo-informatics…
Grant will partially fund research to enable faster development, with a higher probability of success, of new plant-based compounds (precision botanics) for the benefit of BioHarvest's CDMO customers and partners Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 15, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based…
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 13, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will participate in a fireside chat at the upcoming Maxim Health, Wellness & Longevity Conference, to be held virtually on July…
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will present at the upcoming BIO International Convention, to be held on June 22-25, in San Diego, California. Presentation Details: Session: Company Presentation…
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) announced that it has expanded its collaboration with Tate & Lyle PLC (LSE:TATE) to broaden the scope of their joint sweetener development program to include multiple plant-based sweetener molecules. The expanded partnership builds on an agreement signed in 2024 and follows what the companies described as strong technical progress in developing sweetening solutions for…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BHST.
Senate Trading
No Senate trades found for BHST.
U.S. House Trading
No House trades found for BHST.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.